HES1 and metastatic malignant neoplasm in the lymph nodes: HES1 was found to be associated with tobacco (88.9%; P = .04), tumor size (90.2%; P < .001), tumor vaginal involvement (89.2%; P < .001), lymph node metastasis (87.7%; P < .002), and FIGO stage (89.2%; P < .001).